Release Date: 29/11/13 16:12 Summary: CO2 Appendix 4E and Full Year Report to Shareholders Price Sensitive: Yes Download Document 9.8MB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status